Literature DB >> 3105110

Differential detection of single-chain and two-chain urokinase-type plasminogen activator by a new immunoadsorbent-amidolytic assay (IAA).

A Corti, M L Nolli, G Cassani.   

Abstract

A new immunoadsorbent-amidolytic assay (IAA) for the specific differential detection of two-chain urokinase-type plasminogen activator (tcu-PA) and its single-chain precursor (scu-PA) in cell culture supernatants has been developed. The assay combines the selectivity of immunoassays with the specificity of enzyme activity assays exploiting both the antigenic and enzymatic properties of the two proteins. tcu-PA and scu-PA are selectively immunoadsorbed on the wells of a microtiterplate coated with the monoclonal antibody 5B4 and tested for enzymatic activity before and after activation by plasmin treatment. Both proteins are determined with similar efficiency since overlapping dose-response curves were obtained in the range between 12.5-200 ng/ml. The assay has been used to determine tcu-PA and scu-PA in A431 human epidermoid carcinoma cell supernatants. The analytical recoveries for tcu-PA and scu-PA added to A431 cell supernatants were 95.2% and 96.9% respectively. The intra- and inter-assay variations (CV) were 5.5% and 9.0% for tcu-PA and 9.7% and 9.8% for scu-PA respectively.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3105110

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  The optimization of serum-free medium for the production of the scu-PA by the addition of algal extracts.

Authors:  H G Kim; K D Sung; M S Ham; K H Chung; K H Chung; H Y Lee
Journal:  Cytotechnology       Date:  1995-10       Impact factor: 2.058

2.  Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion.

Authors:  H Kobayashi; H Shinohara; H Ohi; M Sugimura; T Terao; M Fujie
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

3.  Increased cell-surface urokinase in advanced ovarian cancer.

Authors:  H Kobayashi; N Moniwa; M Sugimura; H Shinohara; H Ohi; T Terao
Journal:  Jpn J Cancer Res       Date:  1993-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.